Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.

Vaccines (Basel) · 2023 · PMC10611175 · PMID 37896938

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantp -value of <0.001actually significant

For CD4+ cells, the median count was 386 cells/μL (ranging from 79 to 1629) in responders, compared to 154 cells/μL (ranging from 7 to 1007) in non-responders, with a highly significant p -value of <0.001.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.